April 29, 2024 03:40 PM EDT
Pharma
FDA+

No­vo Nordisk's once-week­ly in­sulin will face FDA ad­comm in May, fol­low­ing re­view ex­ten­sion

Nicole DeFeudis

Editor

The FDA’s En­docrino­log­ic and Meta­bol­ic Drugs Ad­vi­so­ry Com­mit­tee will meet on May 24 to dis­cuss No­vo Nordisk’s ap­pli­ca­tion for a once …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

In­tel­lia to cut work­force by 27%, plans com­mer­cial­iza­tion of first CRISPR ther­a­py in 2027

Lil­ly ven­tures in­to pul­monary fi­bro­sis with start­up Me­di­ar

John Maraganore turns to ex-Al­ny­lam col­league to lead his lat­est RNAi bet; Amy­lyx names com­mer­cial chief

With $120M, GSK-al­lied Ouro Med­i­cines throws its hat in­to bur­geon­ing TCE ring

An­oth­er biotech scoops up as­set from Chi­na-based Keymed and nabs $180M

Re­pare paus­es late-stage plans, reshuf­fles pipeline in ef­fort to cut costs

A service from the Financial Times